BioTime Inc (NYSE American:BTX)

Delayed Data
As of Mar 16
 +0.25 / +9.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for BioTime Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 6.00. The median estimate represents a +115.05% increase from the last price of 2.79.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 86.21%
Growthannually -86.76%


Growthquarterly -24.92%
Growthannually -23.11%
Key to the earnings and sales forecast charts.